Request Demo
Last update 23 Jan 2025
Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical Co., Ltd.
Private Company|
1998|
Henan Sheng, China
Last update 23 Jan 2025
Overview
Tags
Other Diseases
Nervous System Diseases
Congenital Disorders
Herbal medicine
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20242460
评价痰热清口服液治疗急性气管-支气管炎（痰热壅肺证）有效性和安全性的多中心、随机、双盲、安慰剂平行对照Ⅲ期临床研究
[Translation] A multicenter, randomized, double-blind, placebo-controlled phase III clinical study to evaluate the efficacy and safety of Tanreqing oral liquid in the treatment of acute tracheobronchitis (Tanreqing lung syndrome)
CTR20190318
以咳嗽消失率为主要疗效指标，评价痰热清口服液治疗急性气管-支气管炎（痰热阻肺证）的Ⅲ临床试验
[Translation] A phase III clinical trial evaluating the effect of Tanreqing oral liquid in the treatment of acute tracheobronchitis (phlegm-heat obstructing lung syndrome) with cough disappearance rate as the primary efficacy indicator
CTR20140022
痰热清口服液与双黄连口服液对照治疗急性上呼吸道感染随机、双盲、阳性药平行对照、多中心Ⅲ期临床研究
[Translation] A randomized, double-blind, positive drug parallel controlled, multicenter phase III clinical study comparing Tanreqing oral liquid with Shuanghuanglian oral liquid in the treatment of acute upper respiratory tract infection
100 Clinical Results associated with Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical Co., Ltd.
Login to view more data
Login to view more data
100 Deals associated with Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical Co., Ltd.
Login to view more data
100 Translational Medicine associated with Shanghai Kaibao Xinyi (Xinxiang) Pharmaceutical Co., Ltd.
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 03 Feb 2025
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3 Clinical
1
3
Approved
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free